All News #Library
Others
Certa Expands GPR68 Platform through Acquisition of OccuRx
19 Dec 2024 //
GLOBENEWSWIRE
Brandon Capital raises $180M for Australia, New Zealand biotechs
04 Jun 2024 //
FIERCE BIOTECH
Certa FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis
19 Feb 2024 //
GLOBENEWSWIRE
Certa presents data from a Phase 2 clinical study highlighting benefit of FT011
15 Nov 2023 //
GLOBENEWSWIRE
Australian biotech touts a positive mid-stage data readout — with old Shire drug
07 Feb 2023 //
ENDPTS
Ex-Shire drug improves outcomes in phase 2 autoimmune trial
06 Feb 2023 //
FIERCE BIOTECH

Market Place
Sourcing Support